once again won the highest score to bid for the "Central Special Fund for Rare Disease Diagnosis and Treatment Capacity Enhancement Project" supported by public welfare funds.

Recently, BGI Genomics has once again won the bid for the "Central Special Lottery Public Welfare Fund to Support the Enhancement of Rare Disease Diagnosis and Treatment Capability Project" with the highest score. Previously, BGI Genomics was also awarded the project, and has provided genetic testing services to over 30,000 rare disease patients and their families.